Skip to main content
OpenTrials

Clinical trial condition

Recurrent Childhood Ependymoma

Explore clinical trials studying Recurrent Childhood Ependymoma. Study availability and eligibility vary by location and protocol.

27 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Recurrent Childhood Ependymoma trial results

Completed

Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma

NCT00381797

Conditions
Central Nervous System Diseases, Central Nervous System Neoplasms, Childhood Cerebral Anaplastic Astrocytoma, +22 more
Locations
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Lurie Children's Hospital-Chicago Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors

NCT00326664

Conditions
Astrocytoma, Central Nervous System Diseases, Central Nervous System Neoplasms, +47 more
Locations
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Lurie Children's Hospital-Chicago Chicago, Illinois, United States
  • Dana-Farber/Harvard Cancer Center Boston, Massachusetts, United States
View Trial Details
Completed

Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma

NCT01462695

Conditions
Astrocytoma, Childhood Cerebellar Anaplastic Astrocytoma, Childhood Cerebral Anaplastic Astrocytoma, +19 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group Downey, California, United States
View all 96 locations
View Trial Details
Completed

Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma

NCT00994500

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +90 more
Locations
  • Childrens Memorial Hospital Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions